All Q2 FY26 results →
OD

OSEL Devices Ltd

Q2 FY26Healthcare Equipment & Supplies

OSEL Devices Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹401
Market cap₹743 Cr
P/E25.4
Updated23 Aug 2026
Read4 min read

The short version

Expecting good growth driven primarily by Philips mobile phone sales, especially with smartphones adding volume. The company is targeting overall growth of 20%-25% in the coming years (Page 13).

From OSEL Devices Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Expecting good growth driven primarily by Philips mobile phone sales, especially with smartphones adding volume.
  • LED segment has huge market potential with ongoing OEM orders and expected export sales contributing to growth.
  • Hearing aids segment projected to grow steadily at 20%-25% overall.
  • Feature phone market targeted to capture a significant share of the INR 9,000-10,000 crore market, aiming to become a leading player in 2-3 years.
  • Currently seeing around 2,000 feature phone activations daily, with realization per phone around INR 850 and EBITDA margins of 15%-20%.
  • Smartphone introduction planned by December 2025 with production scale-up expected by March 2026.
  • Continued expansion in distribution network across India, now present in 18 states with 120 distributors.

2 more points from OSEL Devices Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what OSEL Devices Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Currently, no immediate capex planned for mobile phone division expansion; capex will be considered once stable, regular orders (3-5 lakh units/month) are established (Page 6).
  • Capex will be required later to set up in-house manufacturing once monthly order volumes stabilize (Page 6).
  • Land acquisition at JNPT (five acres) approved for warehousing and manufacturing setup aimed for domestic, international, and re-export business, indicating future capital investment in infrastructure (Page 11).
  • Additional working capital requirements anticipated as business grows; company has good banking support for these needs (Page 13).

2 more points from OSEL Devices Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Healthcare Equipment & Supplies

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 3
2Q-Line Biotech
Rev 2Mar 1
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what OSEL Devices Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Current order book: Around 70 to 80 orders in hand, expected to be delivered before March 2026.
  • Large ongoing order: Kotak order with over 100+ branches completed, continuing deliveries across Mumbai, Delhi, and nationwide.
  • Mobile phone orders: Initial pilot order of 1 lakh units completed, followed by a 3 lakh units order, targeting 5 lakh units order by December.
  • OEM LED business: Already commenced with INR 20 crores of business done in the first half, with additional export orders and more tie-ups in the pipeline.

2 more points from OSEL Devices Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Others in Healthcare Equipment & Supplies this season

  • Aprameya Enginee (Q2 FY26)

    H1FY26 Revenue from Operations: Rs 421.4 Mn, up 343% YoY from Rs 92.7 Mn in H1FY25. Key investor presentation takeaways from Aprameya Engineering Ltd's Q2 FY26

  • Vaidya Sane (Q2 FY26)

    Ongoing construction and CAPEX of about INR 25-30 crores for capacity expansion at Khopoli and Nagpur hospitals. Key concall takeaways from Vaidya Sane's Q2…

  • Earkart (Q2 FY26)

    Earkart has already secured government orders worth approximately ₹9 crores in the current fiscal year (Page 8, 7th excerpt). Key concall takeaways from…

  • QMS Medical Allied Services Ltd (Q2 FY26)

    The only related transaction noted is the recent acquisition of Saarathi increasing stake from 51% to 76%, but no fundraising details were shared with respect…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

OSEL Devices Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were OSEL Devices Ltd Q2 FY26 results?

Expecting good growth driven primarily by Philips mobile phone sales, especially with smartphones adding volume. The company is targeting overall growth of 20%-25% in the coming years (Page 13).

What is OSEL Devices Ltd share price analysis?

OSEL Devices Ltd currently shows a neutral. The stock trades at a P/E of 25.4 with a market cap of ₹743 Cr. Investors should review the full earnings analysis for detailed insights.

Is OSEL Devices Ltd planning capital expenditure?

Currently, no immediate capex planned for mobile phone division expansion; capex will be considered once stable, regular orders (3-5 lakh units/month) are established (Page 6).

Keep OSEL Devices Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.